DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
46 hedge funds and large institutions have $5.18M invested in DMK Pharmaceuticals Corporation Common Stock in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
Holders
46
Holding in Top 10
–
Calls
$1.32M
Puts
$131K
Top Buyers
| 1 | +$795K | |
| 2 | +$340K | |
| 3 | +$198K | |
| 4 |
VCA
Verdence Capital Advisors
Hunt Valley,
Maryland
|
+$69K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$44K |
Top Sellers
| 1 | -$128K | |
| 2 | -$42K | |
| 3 | -$41.6K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$19K |
| 5 |
LFAS
Level Four Advisory Services
Dallas,
Texas
|
-$16.8K |